Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L H

Showing results (171-180 of 441) with videos related to

Pageof 45
Sort By:
International Urology and Nephrology|January 16, 2018
Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral centerJ L H Ruud Bosch, Francis Vekeman, Mei Sheng Duh, et al.
The Journal of Urology|March 5, 2018
Shared Decision Making in Prostate Cancer Care-Encouraging Every Patient to be Actively Involved in Decision Making or Ensuring the Patient Preferred Level of Involvement?Marie-Anne van Stam, Arwen H Pieterse, Henk G van der Poel, et al.
Oncotarget|April 21, 2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinomaSuzan Stelloo, Joyce Sanders, Ekaterina Nevedomskaya, et al.
European Urology|October 24, 2003
Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph projectK M C Verhamme, J P Dieleman, G S Bleumink, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2026
An autoimmunity-associated allele of <i>PTPN22</i> enhances innate antiviral immunity to protect against acute coronavirus infectionAlec M Bevis, Kathryn J L H Rosa, Nancy Schwarting, et al.
Urologic Oncology|March 26, 2017
How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancerRomy E D Lamers, Maarten Cuypers, Marieke de Vries, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 2005
[Results from 10 years of preimplantation-genetic diagnostics in The Netherlands]C E M de Die-Smulders, J A Land, J C F M Dreesen, et al.
European Urology|August 20, 2013
Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate CancerLeonard P Bokhorst, Chris H Bangma, Geert J L H van Leenders, et al.
The American Journal of Surgical Pathology|November 26, 2009
False-negative prostate needle biopsies: frequency, histopathologic features, and follow-upTineke Wolters, Theodorus H van der Kwast, Cornelis J Vissers, et al.
International Journal of Impotence Research|August 31, 2007
Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen StudyB W V Schouten, A M Bohnen, J L H R Bosch, et al.
Pageof 45

Showing results (171-180 of 441) with videos related to

Sort By:
Pageof 45
International Urology and Nephrology|January 16, 2018
Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral centerJ L H Ruud Bosch, Francis Vekeman, Mei Sheng Duh, et al.
The Journal of Urology|March 5, 2018
Shared Decision Making in Prostate Cancer Care-Encouraging Every Patient to be Actively Involved in Decision Making or Ensuring the Patient Preferred Level of Involvement?Marie-Anne van Stam, Arwen H Pieterse, Henk G van der Poel, et al.
Oncotarget|April 21, 2016
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinomaSuzan Stelloo, Joyce Sanders, Ekaterina Nevedomskaya, et al.
European Urology|October 24, 2003
Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph projectK M C Verhamme, J P Dieleman, G S Bleumink, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2026
An autoimmunity-associated allele of <i>PTPN22</i> enhances innate antiviral immunity to protect against acute coronavirus infectionAlec M Bevis, Kathryn J L H Rosa, Nancy Schwarting, et al.
Urologic Oncology|March 26, 2017
How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancerRomy E D Lamers, Maarten Cuypers, Marieke de Vries, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 2005
[Results from 10 years of preimplantation-genetic diagnostics in The Netherlands]C E M de Die-Smulders, J A Land, J C F M Dreesen, et al.
European Urology|August 20, 2013
Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate CancerLeonard P Bokhorst, Chris H Bangma, Geert J L H van Leenders, et al.
The American Journal of Surgical Pathology|November 26, 2009
False-negative prostate needle biopsies: frequency, histopathologic features, and follow-upTineke Wolters, Theodorus H van der Kwast, Cornelis J Vissers, et al.
International Journal of Impotence Research|August 31, 2007
Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen StudyB W V Schouten, A M Bohnen, J L H R Bosch, et al.
Pageof 45